VXRT — Vaxart Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapTurnaround

Annual balance sheet for Vaxart, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	166	95.7	39.7	51.7	63.8
Net Total Accounts Receivable
Net Total Receivables	0.071	0.02	3.01	12	51.3
Prepaid Expenses
Total Current Assets	169	99.5	45.5	68.3	136
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19.8	41.3	36.6	29.1	16.9
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	221	154	91.8	166	186
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10.8	17.9	13.7	90.9	86.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	33.6	43.3	34	107	98.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	188	111	57.8	58.9	87.8
Total Liabilities & Shareholders' Equity	221	154	91.8	166	186
Total Common Shares Outstanding